Pneumonia hospitalizations and mortality in children 3 – 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)

Pneumococcal conjugate vaccine ten valent (PCV 10) was introduced into Nigeria in three phases. Phase 3 introduction started in August 2016. However, its impact on pneumonia admissions and mortality among vaccinated Nigerian children has not been determined. Data in the period before PCV-10 introduc...

Full description

Bibliographic Details
Main Authors: Jalo Iliya, Denis R. Shatima, Beckie N. Tagbo, Adejumoke I. Ayede, Abieyuwa O. Fagbohun, Aliu Rasaq, Sarah Nalban, Isaac W. Elon, Ramatu Mohammed-Nafiu, Patience Ahmed, Oladapo B. Oyewole, Ayobami A. Bakare, Bidemi O. Yusuf, Olugbenga O. Akinrinoye, William N. Ogala, Adegoke G. Falade
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2162289